Specify a stock or a cryptocurrency in the search bar to get a summary
Willow Biosciences Inc
3D7Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation; and a multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada. Address: 202, 1201-5th Street SW, Calgary, AB, Canada, T2R 0Y6
Analytics
WallStreet Target Price
2.71 CADP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 3D7
Dividend Analytics 3D7
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 3D7
Stock Valuation 3D7
Financials 3D7
Results | 2019 | Dynamics |